211 related articles for article (PubMed ID: 25499260)
1. Incidence of cervical precancers among HIV-seropositive women.
Massad LS; Xie X; D'Souza G; Darragh TM; Minkoff H; Wright R; Colie C; Sanchez-Keeland L; Strickler HD
Am J Obstet Gynecol; 2015 May; 212(5):606.e1-8. PubMed ID: 25499260
[TBL] [Abstract][Full Text] [Related]
2. Long-term cumulative incidence of cervical intraepithelial neoplasia grade 3 or worse after abnormal cytology: impact of HIV infection.
Massad LS; Pierce CB; Minkoff H; Watts DH; Darragh TM; Sanchez-Keeland L; Wright RL; Colie C; D'Souza G
Int J Cancer; 2014 Apr; 134(8):1854-61. PubMed ID: 24170366
[TBL] [Abstract][Full Text] [Related]
3. Effect of human immunodeficiency virus infection on the prevalence and incidence of vaginal intraepithelial neoplasia.
Massad LS; Xie X; Greenblatt RM; Minkoff H; Sanchez-Keeland L; Watts DH; Wright RL; D'Souza G; Merenstein D; Strickler H
Obstet Gynecol; 2012 Mar; 119(3):582-9. PubMed ID: 22353957
[TBL] [Abstract][Full Text] [Related]
4. Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection.
Keller MJ; Burk RD; Xie X; Anastos K; Massad LS; Minkoff H; Xue X; D'Souza G; Watts DH; Levine AM; Castle PE; Colie C; Palefsky JM; Strickler HD
JAMA; 2012 Jul; 308(4):362-9. PubMed ID: 22820789
[TBL] [Abstract][Full Text] [Related]
5. Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results.
Harris TG; Burk RD; Palefsky JM; Massad LS; Bang JY; Anastos K; Minkoff H; Hall CB; Bacon MC; Levine AM; Watts DH; Silverberg MJ; Xue X; Melnick SL; Strickler HD
JAMA; 2005 Mar; 293(12):1471-6. PubMed ID: 15784870
[TBL] [Abstract][Full Text] [Related]
6. Natural history of grade 1 cervical intraepithelial neoplasia in women with human immunodeficiency virus.
Massad LS; Evans CT; Minkoff H; Watts DH; Strickler HD; Darragh T; Levine A; Anastos K; Moxley M; Passaro DJ
Obstet Gynecol; 2004 Nov; 104(5 Pt 1):1077-85. PubMed ID: 15516404
[TBL] [Abstract][Full Text] [Related]
7. Association of cervical precancer with human papillomavirus types other than 16 among HIV co-infected women.
Massad LS; Xie X; Burk RD; D'Souza G; Darragh TM; Minkoff H; Colie C; Burian P; Palefsky J; Atrio J; Strickler HD
Am J Obstet Gynecol; 2016 Mar; 214(3):354.e1-6. PubMed ID: 26433170
[TBL] [Abstract][Full Text] [Related]
8. Recent increase in incidence of cervical precancerous lesions in Norway: Nationwide study from 1992 to 2016.
Orumaa M; Leinonen MK; Campbell S; Møller B; Myklebust TÅ; Nygård M
Int J Cancer; 2019 Nov; 145(10):2629-2638. PubMed ID: 30734284
[TBL] [Abstract][Full Text] [Related]
9. Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.
Ogilvie GS; van Niekerk D; Krajden M; Smith LW; Cook D; Gondara L; Ceballos K; Quinlan D; Lee M; Martin RE; Gentile L; Peacock S; Stuart GCE; Franco EL; Coldman AJ
JAMA; 2018 Jul; 320(1):43-52. PubMed ID: 29971397
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.
Sánchez-Lander J; Cortiñas P; Loureiro CL; Pujol FH; Medina F; Capote-Negrín L; Bianchi G; García-Barriola V; Ruiz-Benni A; Avilán-Rovira J; Acosta H
Cancer Epidemiol; 2012 Oct; 36(5):e284-7. PubMed ID: 22608058
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
[TBL] [Abstract][Full Text] [Related]
12. Outcome after negative colposcopy among human immunodeficiency virus-infected women with borderline cytologic abnormalities.
Massad LS; Evans CT; Strickler HD; Burk RD; Watts DH; Cashin L; Darragh T; Gange S; Lee YC; Moxley M; Levine A; Passaro DJ
Obstet Gynecol; 2005 Sep; 106(3):525-32. PubMed ID: 16135582
[TBL] [Abstract][Full Text] [Related]
13. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. New York Cervical Disease Study.
Wright TC; Ellerbrock TV; Chiasson MA; Van Devanter N; Sun XW
Obstet Gynecol; 1994 Oct; 84(4):591-7. PubMed ID: 8090399
[TBL] [Abstract][Full Text] [Related]
14. Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008-2015.
Cleveland AA; Gargano JW; Park IU; Griffin MR; Niccolai LM; Powell M; Bennett NM; Saadeh K; Pemmaraju M; Higgins K; Ehlers S; Scahill M; Johnson Jones ML; Querec T; Markowitz LE; Unger ER;
Int J Cancer; 2020 Feb; 146(3):810-818. PubMed ID: 30980692
[TBL] [Abstract][Full Text] [Related]
15. Impact of immunosuppression and region of birth on risk of cervical intraepithelial neoplasia among migrants living with HIV in Sweden.
Carlander C; Wagner P; Svedhem V; Elfgren K; Westling K; Sönnerborg A; Sparén P
Int J Cancer; 2016 Oct; 139(7):1471-9. PubMed ID: 27177207
[TBL] [Abstract][Full Text] [Related]
16. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
17. High rates of cervical cancer among HIV-infected women at a referral hospital in Malawi.
Kohler RE; Tang J; Gopal S; Chinula L; Hosseinipour MC; Liomba NG; Chiudzu G
Int J STD AIDS; 2016 Aug; 27(9):753-60. PubMed ID: 26130691
[TBL] [Abstract][Full Text] [Related]
18. Incidence of abnormal cervical and vaginal cytology among women over age 65 years living with human immunodeficiency virus.
Stewart KA; Allen SM; Chesnokova AE; Syed F; Levison JE
Am J Obstet Gynecol; 2020 May; 222(5):486.e1-486.e10. PubMed ID: 31678094
[TBL] [Abstract][Full Text] [Related]
19. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
Dijkstra MG; van Zummeren M; Rozendaal L; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ; Berkhof J
BMJ; 2016 Oct; 355():i4924. PubMed ID: 27702796
[TBL] [Abstract][Full Text] [Related]
20. Frequency of high-grade squamous cervical lesions among women over age 65 years living with HIV.
Massad LS; Xie X; Minkoff HL; Michel KG; D'Souza G; Wang CC; Konkle-Parker D; Ofotokun I; Fischl MA; Rahangdale L; Strickler HD
Am J Obstet Gynecol; 2021 Oct; 225(4):411.e1-411.e7. PubMed ID: 33957115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
